4-cyano-3-[3-(difluoromethoxy)phenyl]-N-(3-methyl-1,1-dioxothietan-3-yl)-1-propan-2-ylindazole-6-carboxamide
C23H22F2N4O4S — CID 162359316
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-cyano-3-[3-(difluoromethoxy)phenyl]-N-(3-methyl-1,1-dioxothietan-3-yl)-1-propan-2-ylindazole-6-carboxamide
4-cyano-3-[3-(difluoromethoxy)phenyl]-N-(3-methyl-1,1-dioxothietan-3-yl)-1-propan-2-ylindazole-6-carboxamide (PubChem CID 162359316) has the molecular formula C23H22F2N4O4S and a molecular weight of 488.52 g/mol. Its IUPAC name is 4-cyano-3-[3-(difluoromethoxy)phenyl]-N-(3-methyl-1,1-dioxothietan-3-yl)-1-propan-2-ylindazole-6-carboxamide.
Molecular Properties
| Compound Name | 4-cyano-3-[3-(difluoromethoxy)phenyl]-N-(3-methyl-1,1-dioxothietan-3-yl)-1-propan-2-ylindazole-6-carboxamide |
|---|---|
| PubChem CID | 162359316 |
| Molecular Formula | C23H22F2N4O4S |
| Molecular Weight | 488.52 g/mol |
| Exact Mass | 488.13 |
| IUPAC Name | 4-cyano-3-[3-(difluoromethoxy)phenyl]-N-(3-methyl-1,1-dioxothietan-3-yl)-1-propan-2-ylindazole-6-carboxamide |
| SMILES | CC(C)n1nc(-c2cccc(OC(F)F)c2)c2c(C#N)cc(C(=O)NC3(C)CS(=O)(=O)C3)cc21 |
| InChI | InChI=1S/C23H22F2N4O4S/c1-13(2)29-18-9-15(21(30)27-23(3)11-34(31,32)12-23)7-16(10-26)19(18)20(28-29)14-5-4-6-17(8-14)33-22(24)25/h4-9,13,22H,11-12H2,1-3H3,(H,27,30) |
| InChIKey | DOYNKLBHFRTWGX-UHFFFAOYSA-N |
| XLogP | 3.67 |
| TPSA | 114.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 488.52 |
| LogP ≤ 5 | 3.67 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162359316 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.